CRNX
Crinetics Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.15B
P/E Ratio
—
EPS
$-4.91
Beta
0.31
52W High
$57.99
52W Low
$25.83
50-Day MA
$41.84
200-Day MA
$39.86
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for rare endocrine diseases and endocrine-related tumors. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $7.70M |
| Gross Profit (TTM) | $-325.44M |
| EBITDA | $-512.88M |
| Operating Margin | -2170.00% |
| Return on Equity | -40.20% |
| Return on Assets | -25.20% |
| Revenue/Share (TTM) | $0.08 |
| Book Value | $10.38 |
| Price-to-Book | 3.93 |
| Price-to-Sales (TTM) | 539.17 |
| EV/Revenue | 379.27 |
| EV/EBITDA | -13.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 158.40% |
| Shares Outstanding | $104.70M |
| Float | $96.25M |
| % Insiders | 2.00% |
| % Institutions | 110.22% |
Historical Volatility
HV 10-Day
59.54%
HV 20-Day
50.50%
HV 30-Day
46.86%
HV 60-Day
44.75%
HV Rank
32.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($83.50 target)
2
Strong Buy11
Buy1
HoldData last updated: 4/10/2026